Novel insights on GM1 and Parkinson's disease: A critical review

被引:0
|
作者
Maria Fazzari
Erika Di Biase
Giulia Lunghi
Laura Mauri
Elena Chiricozzi
Sandro Sonnino
机构
[1] University of Milan,Department of Medical Biotechnology and Translational Medicine
来源
Glycoconjugate Journal | 2022年 / 39卷
关键词
GM1 ganglioside; GM1 oligosaccharide; Parkinson's disease; Neuronale receptors;
D O I
暂无
中图分类号
学科分类号
摘要
GM1 is a crucial component of neuronal membrane residing both in the soma and nerve terminals. As reported in Parkinson’s disease patients, the reduction of GM1 determines the failure of fundamental functional processes leading to cumulative cell distress up to neuron death. This review reports on the role of GM1 in the pathogenesis of the disease, illustrating the current data available but also hypotheses on the additional mechanisms in which GM1 could be involved and which require further study. In the manuscript we discuss these points trying to explain the role of diminished content of brain GM1, particularly in the nigro-striatal system, in Parkinson’s disease etiology and progression.
引用
收藏
页码:27 / 38
页数:11
相关论文
共 50 条
  • [1] Novel insights on GM1 and Parkinson's disease: A critical review
    Fazzari, Maria
    Di Biase, Erika
    Lunghi, Giulia
    Mauri, Laura
    Chiricozzi, Elena
    Sonnino, Sandro
    GLYCOCONJUGATE JOURNAL, 2022, 39 (01) : 27 - 38
  • [2] GM1 ganglioside in the treatment of Parkinson's disease
    Schneider, JS
    SPHINGOLIPIDS AS SIGNALING MODULATORS IN THE NERVOUS SYSTEM, 1998, 845 : 363 - 373
  • [3] A critical role for GM1 ganglioside in the pathophysiology and potential treatment of Parkinson’s disease
    J. S. Schneider
    Glycoconjugate Journal, 2022, 39 : 13 - 26
  • [4] A critical role for GM1 ganglioside in the pathophysiology and potential treatment of Parkinson's disease
    Schneider, J. S.
    GLYCOCONJUGATE JOURNAL, 2022, 39 (01) : 13 - 26
  • [5] The Key Role of GM1 Ganglioside in Parkinson's Disease
    Chowdhury, Suman
    Ledeen, Robert
    BIOMOLECULES, 2022, 12 (02)
  • [6] Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review
    Zhang, Wenchao
    Krafft, Paul R.
    Wang, Tianlong
    Zhang, John H.
    Li, Li
    Tang, Jiping
    CELL TRANSPLANTATION, 2019, 28 (06) : 657 - 661
  • [7] A delayed start trial of GM1 ganglioside in Parkinson's disease
    Schneider, J. S.
    Sendek, S.
    Gollomp, S. M.
    Colcher, A.
    Cambi, F.
    Du, W.
    MOVEMENT DISORDERS, 2011, 26 : S139 - S139
  • [8] GM1 Oligosaccharide Efficacy in Parkinson's Disease: Protection against MPTP
    Fazzari, Maria
    Lunghi, Giulia
    Henriques, Alexandre
    Callizot, Noelle
    Ciampa, Maria Grazia
    Mauri, Laura
    Prioni, Simona
    Carsana, Emma Veronica
    Loberto, Nicoletta
    Aureli, Massimo
    Mari, Luigi
    Sonnino, Sandro
    Chiricozzi, Elena
    Di Biase, Erika
    BIOMEDICINES, 2023, 11 (05)
  • [9] The relationship between depletion of brain GM1 ganglioside and Parkinson's disease
    Sonnino, Sandro
    FEBS OPEN BIO, 2023, 13 (09): : 1548 - 1557
  • [10] Therapeutic effects of GM1 on Parkinson's disease in rats and its mechanism
    Ba, Xiao-hong
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2016, 126 (02) : 163 - 167